HOME › DRUGS › FEDRATINIB
ACTIVE SUBSTANCE / INN

FEDRATINIB

Brand name(s): Inrebic
EMA LISTED
AUTHORISED
Myeloproliferative Disorders;Primary Myelofibrosis
ACTIVE SUBSTANCE
Fedratinib
REGULATORS
EMA
SPONSORS / MAH
Bristol Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
InrebicBristol Myers Squibb Pharma EEIGAuthorised08/02/2021Myeloproliferative Disorders;Primary Myelofibrosis

FULL INTELLIGENCE ON FEDRATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →